Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01022333
Recruitment Status : Unknown
Verified November 2009 by Women's College Hospital.
Recruitment status was:  Recruiting
First Posted : December 1, 2009
Last Update Posted : December 1, 2009
Sponsor:
Collaborator:
BioResponse
Information provided by:
Women's College Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2010
Estimated Study Completion Date : December 2010